APA (7th ed.) Citation

S, S., Y, Z., M, P., X, Y., S, A., J, W., . . . JP, B. (2026). Evolving landscape of drug development for pediatric rare diseases-from successes to strategies for addressing unmet needs. Journal of pharmaceutical sciences, 115(9), 104401. https://doi.org/10.1016/j.xphs.2026.104401

Chicago Style (17th ed.) Citation

S, Stern, et al. "Evolving Landscape of Drug Development for Pediatric Rare Diseases-from Successes to Strategies for Addressing Unmet Needs." Journal of Pharmaceutical Sciences 115, no. 9 (2026): 104401. https://doi.org/10.1016/j.xphs.2026.104401.

MLA (9th ed.) Citation

S, Stern, et al. "Evolving Landscape of Drug Development for Pediatric Rare Diseases-from Successes to Strategies for Addressing Unmet Needs." Journal of Pharmaceutical Sciences, vol. 115, no. 9, 2026, p. 104401, https://doi.org/10.1016/j.xphs.2026.104401.